Xeris Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Xeris Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xeris Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xeris Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 1.8M | 8.14 |
| 2025-06-30 | $1.1M | 228k | 4.67 |
| 2025-03-31 | $4.7M | 864k | 5.49 |
| 2024-12-31 | $5.9M | 1.7M | 3.39 |
| 2024-09-30 | $807k | 283k | 2.85 |
| 2024-06-30 | $368k | 164k | 2.25 |
| 2024-03-31 | $435k | 197k | 2.21 |
| 2023-12-31 | $316k | 134k | 2.35 |
| 2023-09-30 | $139k | 74k | 1.86 |
| 2023-06-30 | $8.8k | 3.4k | 2.62 |
| 2023-03-31 | $78k | 48k | 1.63 |
| 2022-12-31 | $35k | 26k | 1.33 |
| 2022-09-30 | $22k | 15k | 1.49 |
| 2022-06-30 | $5.0k | 3.1k | 1.64 |
| 2022-03-31 | $129k | 50k | 2.56 |
| 2021-12-31 | $37k | 13k | 2.90 |